| 47988-1 |
Progesterone^6th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Progesterone [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47988-1 |
|
|
|
|
Observation |
|
|
|
0 |
Progest sp6 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 47989-9 |
Progesterone^7th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Progesterone [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47989-9 |
|
|
|
|
Observation |
|
|
|
0 |
Progest sp7 p chal SerPl-sCnc |
|
|
|
N |
|
^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 4799-3 |
HLA-B75(15) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B75(15) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4799-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B75(15) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47990-7 |
Progesterone^8th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Progesterone [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47990-7 |
|
|
|
|
Observation |
|
|
|
0 |
Progest sp8 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 47991-5 |
Progesterone^9th specimen post XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Progesterone [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47991-5 |
|
|
|
|
Observation |
|
|
|
0 |
Progest sp9 p chal SerPl-sCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Level; p chal; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 47994-9 |
Bilirubin |
SCnc |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Bilirubin.total [Moles/volume] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47994-9 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub BldCo-sCnc |
|
|
|
N |
|
Bili; Bilirubins; Billirubin; Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 47995-6 |
Glucose |
SCnc |
BldCo |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Cord blood |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
47995-6 |
|
|
|
|
Both |
|
|
|
0 |
Glucose BldCo-sCnc |
|
|
|
N |
|
Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; Glu; Gluc; Glucoseur; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 47996-4 |
Adenosine deaminase binding protein |
ACnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Adenosine deaminase binding protein [Units/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
CHEM |
|
47996-4 |
|
|
|
|
Both |
|
|
|
0 |
Adenosine deaminase BP Ur-aCnc |
|
|
|
N |
|
ABP; ADA; AdAbp; Adenosine deaminase BP; ADO; ANED; Arbitrary concentration; Bind; Chemistry; Medication stress; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.7 |
2.21 |
|
|
|
|
|
|
|
K[IU]/L |
|
|
|
0 |
| 47997-2 |
Genetic variant clinical significance |
Imp |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Genetic variant clinical significance [Interpretation] in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MISC |
|
47997-2 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Genetic variant clin sig Bld/T-Imp |
|
|
|
N |
|
Blood; Genetic variant clin sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; Variant Interpretation; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 47998-0 |
DNA sequence variation display name |
Txt |
Bld/Tiss |
Pt |
Nar |
Molgen |
|
ACTIVE |
DNA sequence variation display name [Text] Narrative |
|
MIN |
DefinitionDescription |
|
|
|
Heterozygous c.724A>T (p.Ile242Phe), Exon 5, GLA, Presumed Pathogenic |
|
|
|
|
|
HL7.GENETICS |
|
47998-0 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
DNA seq var display name |
|
|
|
N |
|
Blood; Deoxyribonucleic acid; DNA change; DNA seq var; DNA seq var display name; Genetic; Genetic variant for display; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Narrative; PCR; Point in time; Random; Report; Text; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 47999-8 |
DNA region name |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
DNA region name [Identifier] |
|
MIN |
DefinitionDescription |
|
|
|
exon 1, x1, intron 1, promoter, etc.. |
|
|
|
|
|
HL7.GENETICS |
|
47999-8 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
DNA region name |
|
|
|
N |
|
Blood; Deoxyribonucleic acid; Gene region; Genetic; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Ident; Identifier; Inherited; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48-9 |
Bacampicillin |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
48-9 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Bacampicillin Islt MIC |
|
|
|
|
|
Albaxin; Ambacamp; Ambaxin; Amplibac; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bacacil; Bacampicin; Bacocil; Carampicillin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Penglobe; Point in time; Random; Sprectrobid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Velbacampin |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 480-4 |
Talampicillin |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
480-4 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Talampicillin Islt MIC |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Fisiopen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Talpen; Ticillina |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4800-9 |
HLA-B76(15) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B76(15) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4800-9 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B76(15) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 48000-4 |
Chromosome |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Chromosome [Identifier] in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MISC |
|
48000-4 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Chromosome Bld/T |
|
|
|
N |
|
Blood; Chromosom; Chromosomes; Ident; Identifier; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Component name was confusing since sex chromosomes (X & Y) are not numbers. Updated description for more clarification and added an answer list. |
0 |
| 48001-2 |
Chromosome region |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Cytogenetic (chromosome) location |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MISC |
|
48001-2 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Cyto loc ID |
|
|
|
N |
|
Blood; Chromosom; Chromosomes; Cyto loc; Ident; Identifier; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.58 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Updated LCN per CJM for HL7 CG IG |
0 |
| 48002-0 |
Genomic source class |
Type |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Genomic source class [Type] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HL7.GENETICS |
|
48002-0 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Genomic source class |
|
|
|
N |
|
Blood; Genetic; Genetic variant source; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Srce; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48003-8 |
DNA sequence variation identifier |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
DNA sequence variation identifier [Identifier] |
|
MIN |
DefinitionDescription |
|
|
|
rs1057910 (CYP2C9 c.1075), rs9934438 (VKORC1 c.-1639) |
|
|
|
|
|
HL7.GENETICS |
|
48003-8 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
DNA seq var ID |
|
|
|
N |
|
Blood; Deoxyribonucleic acid; DNA change; DNA seq var; DNA seq var ID; Genetic; Genetic variant ID; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Ident; Identifier; Inherited; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48004-6 |
DNA change |
Find |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
DNA change (c.HGVS) |
|
MIN |
DefinitionDescription |
|
|
|
c.509_511delGGA (insertion/deletion), m.2543G>A (substitution), c.1075A (Wild Type) |
|
|
|
|
|
HL7.GENETICS |
|
48004-6 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
DNA change |
|
|
|
N |
|
Blood; Deoxyribonucleic acid; Exchange; Finding; Findings; Genetic; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Inherited; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Replace; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Updated LCN per CJM for HL7 CG IG; Changed Component from "DNA sequence variation" to conform with the balloted HL7 v2 IG |
0 |
| 48005-3 |
Amino acid change |
Find |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Amino acid change (pHGVS) |
|
MIN |
DefinitionDescription |
|
|
|
p.Ile242Phe (Missense), p.Val391Val(Silent), p.Val391(Wild Type), p.Gly61fs (Frameshift) |
|
|
|
|
|
HL7.GENETICS |
|
48005-3 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Amino acid change |
|
|
|
N |
|
Acd; Acids; Blood; Exchange; Finding; Findings; Genetic; Genetics; Genomic; HL7.GENETICS; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Replace; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
Updated LCN per CJM for HL7 CG IG |
0 |
| 48006-1 |
Amino acid change type |
Type |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Amino acid change [Type] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HL7.GENETICS |
|
48006-1 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Amino acid change type |
|
|
|
N |
|
Acd; Acids; Blood; Exchange; Genetic; Genetics; Genomic; HL7.GENETICS; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Replace; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue |
2.58 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48007-9 |
Genetic variant allelic state |
Type |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Genetic variant allelic state [Type] in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
1^Heteroplasmic ^LA |
|
|
|
|
|
MOLPATH.MISC |
|
48007-9 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Genetic variant allelic state Bld/T |
|
|
|
N |
|
Blood; Genetics; Genomic; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue |
2.26 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48008-7 |
Allele name |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Allele name [Identifier] |
|
MIN |
DefinitionDescription |
|
|
|
*1, *2, *3, Hap A (freeform text) |
|
|
|
|
|
HL7.GENETICS |
|
48008-7 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Allele name |
|
|
|
N |
|
Blood; Genetic; Genetics; Genomic; Heredity; Heritable; HL7.GENETICS; Ident; Identifier; Inherited; Molecular genetics; MOLPATH.GENERAL; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 48009-5 |
Genechip manufacturer ID |
ID |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
Genechip manufacturer ID [Identifier] in Blood or Tissue by Molecular genetics method |
|
MIN |
DefinitionDescription |
|
|
|
527362^Third Wave^UNIV |
|
|
|
|
|
MOLPATH.MISC |
|
48009-5 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
Genechip Manufacturer ID Bld/T |
|
|
|
N |
|
Blood; Ident; Identifier; Intradermal; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.26 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4801-7 |
HLA-B76(15) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B76(15) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4801-7 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B76(15) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
